Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Heparin recalled?

Yes — there is an active recall. 1 ongoing FDA recall mention Heparin (118 total). Check the affected lots below.

Recalls are matched by product description. A recall usually affects specific lots, not every package of Heparin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Heparin recalls on record

none so far in 2026; 118 on record, newest first
Class II · Moderate risk

heparin added to 0.9% sodium chloride

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-8100-1 D-0746-2023
Class II · Moderate risk

heparin added to 0.9% sodium chloride

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-8000-1 D-0739-2023
Class II · Moderate risk

heparin added to 0.9% sodium chloride

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-7023-1 D-0732-2023
Class II · Moderate risk

heparin added to 0.9% sodium chloride

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-7022-1 D-0731-2023
Class II · Moderate risk

heparin added to 0.9% sodium chloride

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-7009-1 D-0726-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0432-1 D-0700-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0430-1 D-0699-2023
Class II · Moderate risk

Neonatal PN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0429-1 D-0698-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0428-1 D-0697-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0427-1 D-0696-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0425-1 D-0695-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0423-1 D-0694-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0422-1 D-0693-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0421-1 D-0692-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0420-1 D-0691-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0419-1 D-0690-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0418-1 D-0689-2023
Class II · Moderate risk

Neonatal TPN Starter Bag

Lack of Assurance of Sterility: after an FDA inspection called into question the sterility of the products intended to be sterile.

Terminated Sterility / contamination Central Admixture Pharmacy Services, Inc. NDC 71285-0416-1 D-0688-2023